Takeda Pharmaceutical Company Limited (TKDA) — Financial Flexibility Index
Takeda Pharmaceutical Company Limited (TKDA) has a Financial Flexibility Index of 0.08x as of December 2025. Free cash flow of €595.62 Billion (operating CF €373.25 Billion minus capex €222.37 Billion) represents 0% of total liabilities (€7.76 Trillion). Also explore net asset growth rate of Takeda Pharmaceutical Company Limited to track the company's year-over-year net asset growth rate.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Takeda Pharmaceutical Company Limited Financial Flexibility Index (2017–2025)
Historical Financial Flexibility Index trend for Takeda Pharmaceutical Company Limited across 9 annual periods. Check strategic asset allocation of Takeda Pharmaceutical Company Limited to assess the company's strategic physical and investment asset allocation.
Annual Financial Flexibility Index for Takeda Pharmaceutical Company Limited (2017–2025)
Year-by-year free cash flow to debt coverage for Takeda Pharmaceutical Company Limited. For the full company profile including market capitalisation, see market cap of Takeda Pharmaceutical Company Limited.
| Year | Flexibility Index | Free Cash Flow (EUR) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.20x | €1.44 Trillion | €1.06 Trillion | €7.31 Trillion | ▲ +28.6% |
| 2024 | 0.15x | €1.20 Trillion | €716.34 Billion | €7.83 Trillion | ▼ -27.9% |
| 2023 | 0.21x | €1.61 Trillion | €977.16 Billion | €7.60 Trillion | ▲ +27.4% |
| 2022 | 0.17x | €1.25 Trillion | €1.12 Trillion | €7.49 Trillion | ▲ +14.6% |
| 2021 | 0.15x | €1.12 Trillion | €1.01 Trillion | €7.74 Trillion | ▲ +47.4% |
| 2020 | 0.10x | €796.83 Billion | €669.75 Billion | €8.09 Trillion | ▲ +111.1% |
| 2019 | 0.05x | €406.16 Billion | €328.48 Billion | €8.71 Trillion | ▼ -78.1% |
| 2018 | 0.21x | €444.86 Billion | €377.85 Billion | €2.09 Trillion | ▲ +58.7% |
| 2017 | 0.13x | €323.02 Billion | €261.36 Billion | €2.41 Trillion | — |